1. Home
  2. BIP vs DGX Comparison

BIP vs DGX Comparison

Compare BIP & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIP
  • DGX
  • Stock Information
  • Founded
  • BIP 2007
  • DGX 1967
  • Country
  • BIP Bermuda
  • DGX United States
  • Employees
  • BIP N/A
  • DGX N/A
  • Industry
  • BIP Marine Transportation
  • DGX Medical Specialities
  • Sector
  • BIP Consumer Discretionary
  • DGX Health Care
  • Exchange
  • BIP Nasdaq
  • DGX Nasdaq
  • Market Cap
  • BIP 15.2B
  • DGX 17.5B
  • IPO Year
  • BIP 2008
  • DGX 1996
  • Fundamental
  • Price
  • BIP $32.98
  • DGX $172.26
  • Analyst Decision
  • BIP Strong Buy
  • DGX Buy
  • Analyst Count
  • BIP 5
  • DGX 13
  • Target Price
  • BIP $42.80
  • DGX $177.69
  • AVG Volume (30 Days)
  • BIP 428.4K
  • DGX 1.2M
  • Earning Date
  • BIP 01-30-2025
  • DGX 01-30-2025
  • Dividend Yield
  • BIP 5.01%
  • DGX 1.86%
  • EPS Growth
  • BIP N/A
  • DGX 2.67
  • EPS
  • BIP 0.12
  • DGX 7.69
  • Revenue
  • BIP $21,039,000,000.00
  • DGX $9,872,000,000.00
  • Revenue This Year
  • BIP N/A
  • DGX $10.18
  • Revenue Next Year
  • BIP $6.85
  • DGX $3.82
  • P/E Ratio
  • BIP $270.64
  • DGX $22.37
  • Revenue Growth
  • BIP 17.33
  • DGX 6.70
  • 52 Week Low
  • BIP $24.84
  • DGX $123.66
  • 52 Week High
  • BIP $36.50
  • DGX $172.91
  • Technical
  • Relative Strength Index (RSI)
  • BIP 50.93
  • DGX 70.79
  • Support Level
  • BIP $32.42
  • DGX $166.15
  • Resistance Level
  • BIP $33.58
  • DGX $172.64
  • Average True Range (ATR)
  • BIP 0.81
  • DGX 3.27
  • MACD
  • BIP 0.02
  • DGX 0.74
  • Stochastic Oscillator
  • BIP 79.28
  • DGX 94.96

About BIP Brookfield Infrastructure Partners LP

Brookfield Infrastructure Partners LP is a Bermuda exempted limited partnership that owns and operates quality, long-life assets that generate stable cash flows, by virtue of barriers to entry or other characteristics that tend to appreciate in value over time. It focuses on acquiring infrastructure assets that have low maintenance capital costs and high barriers to entry. The company's segments consist of Utilities, Transport, Midstream, and Data. Geographically, it generates maximum revenue from Canada and also has a presence in Australia, Colombia, United Kingdom, Brazil, United States of America, Chile, Peru, and other countries.

About DGX Quest Diagnostics Incorporated

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.

Share on Social Networks: